Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James M Angelastro

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
International Journal of Cancer|February 3, 2007
The transcription factor ATF5 is widely expressed in carcinomas, and interference with its function selectively kills neoplastic, but not nontransformed, breast cell linesSara E Monaco, James M Angelastro, Matthias Szabolcs, et al.
Cells|February 25, 2023
Targeting Transcription Factors ATF5, CEBPB and CEBPD with Cell-Penetrating Peptides to Treat Brain and Other CancersLloyd A Greene, Qing Zhou, Markus D Siegelin, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|December 31, 2020
Repurposing FDA approved drugs inhibiting mitochondrial function for targeting glioma-stem like cellsSandipan Datta, Thomas Sears, Gino Cortopassi, et al.
Molecular Cancer Research : MCR|November 3, 2019
Dominant-Negative ATF5 Compromises Cancer Cell Survival by Targeting CEBPB and CEBPDXiaotian Sun, Parvaneh Jefferson, Qing Zhou, et al.
Molecular Cancer Research : MCR|June 18, 2009
Identification of a novel DNA binding site and a transcriptional target for activating transcription factor 5 in c6 glioma and mcf-7 breast cancer cellsGuangfu Li, Wenhong Li, James M Angelastro, et al.
Journal of Neuro-Oncology|May 23, 2007
Organotypic distribution of stem cell markers in formalin-fixed brain harboring glioblastoma multiformeRudolph J Schrot, Joyce H Ma, Claudia M Greco, et al.
Cell Death & Disease|September 26, 2019
Dominant-negative ATF5 rapidly depletes survivin in tumor cellsXiaotian Sun, James M Angelastro, David Merino, et al.
Developmental Neurobiology|November 19, 2011
Reciprocal actions of ATF5 and Shh in proliferation of cerebellar granule neuron progenitor cellsHae Young Lee, James M Angelastro, Anna Marie Kenney, et al.
Cells|May 13, 2026
Dpep, a Cell-Penetrating Peptide Targeting ATF5, CEBPB and CEBPD, Synergistically Combines with ABT-263 and Decitabine to Inhibit Cancer Cell Growth and Overcome Dpep ResistanceQing Zhou, Trang Thi Thu Nguyen, James M Angelastro, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|December 18, 2002
Endoplasmic reticulum stress and the unfolded protein response in cellular models of Parkinson's diseaseElizabeth J Ryu, Heather P Harding, James M Angelastro, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
International Journal of Cancer|February 3, 2007
The transcription factor ATF5 is widely expressed in carcinomas, and interference with its function selectively kills neoplastic, but not nontransformed, breast cell linesSara E Monaco, James M Angelastro, Matthias Szabolcs, et al.
Cells|February 25, 2023
Targeting Transcription Factors ATF5, CEBPB and CEBPD with Cell-Penetrating Peptides to Treat Brain and Other CancersLloyd A Greene, Qing Zhou, Markus D Siegelin, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|December 31, 2020
Repurposing FDA approved drugs inhibiting mitochondrial function for targeting glioma-stem like cellsSandipan Datta, Thomas Sears, Gino Cortopassi, et al.
Molecular Cancer Research : MCR|November 3, 2019
Dominant-Negative ATF5 Compromises Cancer Cell Survival by Targeting CEBPB and CEBPDXiaotian Sun, Parvaneh Jefferson, Qing Zhou, et al.
Molecular Cancer Research : MCR|June 18, 2009
Identification of a novel DNA binding site and a transcriptional target for activating transcription factor 5 in c6 glioma and mcf-7 breast cancer cellsGuangfu Li, Wenhong Li, James M Angelastro, et al.
Journal of Neuro-Oncology|May 23, 2007
Organotypic distribution of stem cell markers in formalin-fixed brain harboring glioblastoma multiformeRudolph J Schrot, Joyce H Ma, Claudia M Greco, et al.
Cell Death & Disease|September 26, 2019
Dominant-negative ATF5 rapidly depletes survivin in tumor cellsXiaotian Sun, James M Angelastro, David Merino, et al.
Developmental Neurobiology|November 19, 2011
Reciprocal actions of ATF5 and Shh in proliferation of cerebellar granule neuron progenitor cellsHae Young Lee, James M Angelastro, Anna Marie Kenney, et al.
Cells|May 13, 2026
Dpep, a Cell-Penetrating Peptide Targeting ATF5, CEBPB and CEBPD, Synergistically Combines with ABT-263 and Decitabine to Inhibit Cancer Cell Growth and Overcome Dpep ResistanceQing Zhou, Trang Thi Thu Nguyen, James M Angelastro, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|December 18, 2002
Endoplasmic reticulum stress and the unfolded protein response in cellular models of Parkinson's diseaseElizabeth J Ryu, Heather P Harding, James M Angelastro, et al.
Pageof 4